Elena Nicod

1.5k total citations
40 papers, 1.1k citations indexed

About

Elena Nicod is a scholar working on Economics and Econometrics, Genetics and General Health Professions. According to data from OpenAlex, Elena Nicod has authored 40 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Economics and Econometrics, 7 papers in Genetics and 6 papers in General Health Professions. Recurrent topics in Elena Nicod's work include Health Systems, Economic Evaluations, Quality of Life (28 papers), Pharmaceutical Economics and Policy (18 papers) and Genomics and Rare Diseases (6 papers). Elena Nicod is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (28 papers), Pharmaceutical Economics and Policy (18 papers) and Genomics and Rare Diseases (6 papers). Elena Nicod collaborates with scholars based in United Kingdom, Italy and Spain. Elena Nicod's co-authors include Panos Kanavos, Aris Angelis, Timothy L. Jackson, Federico Grimaccia, Amanda Whittal, Michela Meregaglia, Karen Facey, Andrew Simpson, Sheela Upadhyaya and Michael Drummond and has published in prestigious journals such as SHILAP Revista de lepidopterología, Preventive Medicine and BMJ Open.

In The Last Decade

Elena Nicod

39 papers receiving 1.0k citations

Peers

Elena Nicod

OPHTH

RNMI

PPCH

GHP

Festus Njuguna Kenya

Ligia Fú United States

Mhamed Harif Morocco

Andrea Gibson United States

Nakul Singh United States

Pierre Blaise Belgium

Paul M. Walsh Ireland

Belinda E. Kiely Australia

Evan M. Chen United States

Sandra Nestler-Parr United States

Festus Njuguna Kenya

Elena Nicod

88 ×0.1

274 ×1.0

OPHTH

112 ×0.4

RNMI

614 ×4.1

PPCH

98 ×0.7

GHP

Citations per year, relative to Elena Nicod Elena Nicod (= 1×) peers Festus Njuguna

Countries citing papers authored by Elena Nicod

Since Specialization

Citations

This map shows the geographic impact of Elena Nicod's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elena Nicod with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elena Nicod more than expected).

Fields of papers citing papers by Elena Nicod

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elena Nicod. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elena Nicod. The network helps show where Elena Nicod may publish in the future.

Co-authorship network of co-authors of Elena Nicod

This figure shows the co-authorship network connecting the top 25 collaborators of Elena Nicod. A scholar is included among the top collaborators of Elena Nicod based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elena Nicod. Elena Nicod is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nicod, Elena, Andrew Lloyd, Thomas Morel, et al.. (2022). Improving Interpretation of Evidence Relating to Quality of Life in Health Technology Assessments of Rare Disease Treatments. Patient. 16(1). 7–17. 8 indexed citations

Meregaglia, Michela, Elena Nicod, & Michael Drummond. (2022). The estimation of health state utility values in rare diseases: do the approaches in submissions for NICE technology appraisals reflect the existing literature? A scoping review. The European Journal of Health Economics. 24(7). 1151–1216. 5 indexed citations

Facey, Karen, Jaime Espín, E. Kent, et al.. (2021). Implementing Outcomes-Based Managed Entry Agreements for Rare Disease Treatments: Nusinersen and Tisagenlecleucel. PharmacoEconomics. 39(9). 1021–1044. 35 indexed citations

Nicod, Elena, Michela Meregaglia, Amanda Whittal, et al.. (2021). Consideration of quality of life in the health technology assessments of rare disease treatments. The European Journal of Health Economics. 23(4). 645–669. 11 indexed citations

Whittal, Amanda, Elena Nicod, Sheela Upadhyaya, Michael Drummond, & Karen Facey. (2020). PRO98 Country Specific Approaches to Appraising RARE Disease Treatments: A Case Study Analysis of the IMPACT of Different Processes. Value in Health. 23. S707–S707.

Nicod, Elena, Amanda Whittal, Michael Drummond, & Karen Facey. (2020). Are supplemental appraisal/reimbursement processes needed for rare disease treatments? An international comparison of country approaches. Orphanet Journal of Rare Diseases. 15(1). 189–189. 28 indexed citations

Meregaglia, Michela, Amanda Whittal, Elena Nicod, & Michael Drummond. (2019). PRO157 PREDICTING HEALTH UTILITIES FROM PATIENT-REPORTED OUTCOME MEASURES (PROMS) IN RARE DISEASES: A SYSTEMATIC REVIEW OF MAPPING STUDIES. Value in Health. 22. S871–S871. 1 indexed citations

Nicod, Elena, Amanda Whittal, Michael Drummond, & Karen Facey. (2019). PRO77 INTERNATIONAL VARIATIONS IN THE APPRAISAL OF DRUGS FOR RARE DISEASES; WHAT ARE THE MAIN LESSONS?. Value in Health. 22. S855–S855. 1 indexed citations

Ciani, Oriana, Maria Cucciniello, Francesco Petracca, et al.. (2019). Lung Cancer App (LuCApp) study protocol: a randomised controlled trial to evaluate a mobile supportive care app for patients with metastatic lung cancer. BMJ Open. 9(2). e025483–e025483. 30 indexed citations

10.

Annemans, Lieven, Ségolène Aymé, Yann Le Cam, et al.. (2017). Recommendations from the European Working Group for Value Assessment and Funding Processes in Rare Diseases (ORPH-VAL). Orphanet Journal of Rare Diseases. 12(1). 50–50. 76 indexed citations

11.

Nicod, Elena, Timothy L. Jackson, Federico Grimaccia, et al.. (2015). Direct cost of pars plana vitrectomy for the treatment of macular hole, epiretinal membrane and vitreomacular traction: a bottom-up approach. The European Journal of Health Economics. 17(8). 991–999. 5 indexed citations

12.

Nicod, Elena & Panos Kanavos. (2015). Developing an evidence-based methodological framework to systematically compare HTA coverage decisions: A mixed methods study. Health Policy. 120(1). 35–45. 48 indexed citations

13.

Angelis, Aris, Panos Kanavos, Julio López‐Bastida, et al.. (2015). Social and economic costs and health-related quality of life in non-institutionalised patients with cystic fibrosis in the United Kingdom. BMC Health Services Research. 15(1). 428–428. 47 indexed citations

14.

Nicod, Elena. (2014). Why Are There Differences In Hta Recommendations Across Countries? A Systematic Comparison of Hta Decision Processes for A Sample of Orphan Drugs In Four Countries. Value in Health. 17(7). A540–A540. 2 indexed citations

15.

Nicod, Elena, Timothy L. Jackson, Federico Grimaccia, Aris Angelis, & Panos Kanavos. (2013). Cost Analysis Of Pars Plana Vitrectomy For The Treatment Of Symptomatic Vitreomacular Adhesion: A Bottom-Up Costing Perspective. Value in Health. 16(3). A176–A176. 5 indexed citations

16.

Nicod, Elena & Panos Kanavos. (2013). Inter-Country Variability In Coverage Decisions For Orphan Drugs: Criteria Driving Hta Recommendations In Six Countries. Value in Health. 16(3). A3–A3. 1 indexed citations

17.

Jackson, Timothy L., Elena Nicod, Aris Angelis, et al.. (2013). PARS PLANA VITRECTOMY FOR VITREOMACULAR TRACTION SYNDROME. Retina. 33(10). 2012–2017. 79 indexed citations

18.

Kanavos, Panos & Elena Nicod. (2012). What Is Wrong with Orphan Drug Policies? Suggestions for Ways Forward. Value in Health. 15(8). 1182–1184. 38 indexed citations

19.

Nicod, Elena & Panos Kanavos. (2012). Commonalities and differences in HTA outcomes: A comparative analysis of five countries and implications for coverage decisions. Health Policy. 108(2-3). 167–177. 80 indexed citations

20.

Ferrario, Alessandra, Elena Nicod, & Panos Kanavos. (2011). PHP151 Evidence on the Impact of Managed Entries on Payers, Patients, Manufacturers, and Health Care Workers. Value in Health. 14(7). A360–A361. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact